Pfizer Is Trading As If It's 2009 Again
Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...
Zacks Investment Research on MSN14d
Pfizer (PFE) Stock Moves -0.43%: What You Should Know
The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...
4 Analysts Assess Pfizer: What You Need To Know
Pfizer PFE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Pfizer Inc. stock underperforms Wednesday when compared to competitors
Shares of Pfizer Inc. PFE slipped 1.33% to $25.21 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.12% to 5,712.20 and Dow ...
Yahoo Finance21d
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer (PFE) is one of the stocks ... This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings. Our analysis is essentially ...
Pfizer Inc. stock underperforms Tuesday when compared to competitors
Shares of Pfizer Inc. PFE slipped 2.26% to $25.55 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 5,776.65 and ...
Pfizer drops after report on U.S. probe related to its COVID vaccine success
Pfizer (PFE) stock drops as company faces a federal probe on claims of delaying 2020 Covid vaccine success announcement for ...
US Prosecutors Probe Tip About Timing of Pfizer's COVID Vaccine, WSJ Reports
(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 until after that year's election, the Wall Street Journal ...